PHARMACOLOGICAL THERAPY OF AUTISM SPECTRUM DISORDERS IN THE CLINICAL PRACTICE
|
|
- Horace Marshall
- 5 years ago
- Views:
Transcription
1 ANTON et al. ORIGINAL PAPERS PHARMACOLOGICAL THERAPY OF AUTISM SPECTRUM DISORDERS IN THE CLINICAL PRACTICE Andra ISAC 2, Magdalena KWASIUK 1, Roxana ȘIPOȘ 1, Ioana MICLUȚIA 1, Viorel LUPU 1, Elena PREDESCU 1 1 Iuliu Hațieganu University of Medicine and Pharmacy, Cluj Napoca, Romania 2 Child and Adolescent Psychiatry and Addiction Clinic Children s Emergency Hospital Cluj Napoca, Romania ABSTRACT Although there is no specific pharmacological treatment for autism spectrum disorders (ASD), psychotropic medication is used frequently in clinical practice. 34 patients were included in the study, with ages between 3 and 17 years, treated in the Child and Adolescent Psychiatry Cluj Napoca, during the 1st and 31st January 2015, with a diagnosis of ASD based on DSM IV TR and ICD-10 criteria, after structured clinical interview for infant, child and adolescent disorders (KID-SCID). Exclusion criteria: major somatic disorders, incomplete medical records. The medication taken into consideration included: antipsychotics, methylphenidate, atomoxetine, antidepressants, sleep medication and mood stabilizers. The data was analyzed using SPSS 17. The average age was of 9.26 years, with a high prevalence of male patients (4:1) and the urban area. 70.5% of patients were diagnosed with typical childhood autism, 17.6% with atypical autism and 5.8% with Asperger s syndrome. 56% of patients participate in one therapy session/ week and only 4 % to less than one session/week % have been prescribed psychotropic medication (atypical antipsychotics 23.5%, atomoxetine 8.82%, methylphenidate 14.7% and mood stabilizers 5.8%), with 23.5% of patients having been prescribed 2 or more drugs. Distribution according to gender has been consistent with scientific works and pharmacological therapy is the one described in recent papers. The high number of patients under pharmacological treatment might be explained by the low level of specific behavioral therapy, considerably below the number of recommended hours. Further research is needed to test the appropriate use, efficacy and long-term safety of psychotropic medication in the treatment of ASD. Keywords: autism spectrum disorders, pharmacological therapy, child, adolescent INTRODUCTION Autism spectrum disorders and associated comorbid disorders significantly impact social outcomes, education and health due to their early onset, their lifelong persistence and associated pervasive impairments. Corresponding Author: Andra Isac, Resident Physician, Child and Adolescent Psychiatry and Addiction Clinic Children s Emergency Hospital Cluj Napoca, National Coordinator & IT manager for the Exchange Programme at European Federation of Psychiatric Trainees Individuals with ASD have a very high prevalence of comorbid mental health conditions including attention-deficit hyperactivity disorder (ADHD), learning disabilities, oppositional or conduct disorder, emotional disorders, anxiety and other phobic disorders and chronic tic disorder [1]. Medication may be a helpful therapeutic intervention to manage disabling behavioral and/or mental health symptoms in autistic population; however, there are currently no practice guidelines in place [2]. Volume 3, Issues 3-4, July-Decembre, 2015
2 ISAC et al. Despite the fact that there is no standard medication for treating ASD, patients are prescribed a variety of psychotropic medications (there is scant reliable research evidence supporting this practice for adolescents and adults) [3]. To date we have very little data about the pharmacological treatment of children with ASDs and associated comorbid disorders. Information about prescribing practices and comorbidities is necessary to further research the efficacy and longterm safety of psychotropic medications in this particular patient population. The aim of this study was to investigate the status of practice in child and adolescent mental health services regarding psychopharmacological prescriptions and related comorbidities of children and adolescents with ASD diagnosis. MATERIAL AND METHOD We conducted an analytical retrospective observational study focused on a well-defined category of patients: children with autism spectrum disorders. Data was collected from 34 children aged 3 to 17 years, with a diagnosis of ASD according to the international diagnostic criteria of DSM IV TR and ICD-10 after applying the structured clinical interview for infant, child and adolescent disorders (KID-SCID). For this clinical group (ASD) the main data source was represented by the consultation files within the Child and Adolescent Psychiatry Clinic in Cluj Napoca which also serves neighboring counties. For all children enrolled in the study, we used medical data while ensuring privacy and the subjects identity protection. Children with a known medical condition (metabolic, genetic, neurological or major somatic diseases) and children with incomplete medical records were excluded from the study. We included seven categories of drugs: antipsychotics, stimulants (methylphenidate), atomoxetine, antidepressants, benzodiazepines, sleep medication and mood stabilizers. The prescriptions of each recorded patient were identified, and the proportions of the ASD sample prescribed drug treatment were calculated by drug category and by individual drug. The clinical records of each patient were screened for comorbidities. Diagnostic codes were categorized into eight groups: ADHD, ODD, mental retardation (mild, moderate, and severe), anxiety disorders, sleep disorders and language delay. The proportions of the sample with comorbidities were calculated. The statistical software used for data analysis was the SPSS 17 program. In order to describe the studied population and questionnaire data, we used univariate statistical analysis (mean, median, frequency tables). RESULTS Demographic and clinical characteristics of the ASD The mean age of the patients in the sample was 9.26 years (SD=2.92). The group was comprised of 17.65% girls and 82.35% boys, with 67.65% of them coming from an urban area and 32.35% from a rural environment. In the study sample only 2 children are not enrolled in school. 19 children go to a normal school and 13 children are enrolled in special needs school. Children suffering from cognitive disabilities are recommended to try the inclusion in a normal school with a special curriculum and if needed, with an accompanying person. Multiple categories of autism are described in the chapter for pervasive developmental disorders in ICD 10: childhood autism, atypical autism, other childhood disintegrative disorder, overactive disorder associated with mental retardation and stereotyped movements, Asperger's syndrome, Romanian Journal of Child and Adolescent Psychiatry
3 Pharmacological therapy of Autism Spectrum Disorders in the clinical practice other pervasive developmental disorders, pervasive developmental disorder, unspecified (ICD). In our sample 24 children were diagnosed with typical autism (correspondent term in DSM V is autism spectrum disorders), 6 children with atypical autism and 2 children with Asperger s syndrome. All the patients included in the study had at least one record of a neuropsychiatric comorbidity on or after their first recorded diagnosis of ASD on the database. The most common neuropsychiatric comorbidities were ADHD and mental disabilities (Table I). Table I. Comorbidities Table II. Types of drugs and number of patients taking them In terms of interventions % of the patients were included in a form of psychotherapy. The majority of the children included in the study have at least 1 psychotherapy session per week. Psychotropic drugs were prescribed to 79.41% of the ASD sample. The most frequently prescribed drugs were atypical antipsychotics, atomoxetine, metilphenidate and moodstabilizers. 8 patients have prescriptions for two or more drugs. There are no prescriptions for benzodiazepines and sleep inducing drugs among the children. The most commonly prescribed atypical antipsychotic drugs were risperidone (8 patients) and aripiprazole (7 patients). However, 19 patients out of 34 don`t have prescriptions for any atypical antipsychotic. The majority of children in the studied sample (58.82%) reported behavioral problems, represented by irritability, aggressiveness, self-harm. Individuals with ASD and their family usually demand clinical care for them. In our sample 15 children received drugs for behavioral problems like irritability and aggressiveness. Although there is limited evidence to guide psychotropic medication use in the ASD population, two drugs have shown efficacy for the alleviation of behavioral symptoms in children and adolescents with autistic disorder: risperidone [4] and aripiprazole [5]. In 2006, risperidone was approved by the Food and Drug Administration (FDA) in the USA for the treatment of irritability associated with autistic disorder in 5 to 16 year olds; including aggression and deliberate self-harm. Aripiprazole was also approved by the FDA in 2009 after demonstrating efficacy in the same indication in 6 to 17 year olds [5]. In our sample 15 children out of 18 under pharmacological treatment have prescriptions for atypical antipsychotic and only 3 children have prescriptions for mood stabilizers. In childhood, there may be overlapping diagnostic between ASD and ADHD, making the differential diagnosis difficult. The most frequent comorbidity in our sample was ADHD (73.53%). Despite this, only 47% of children Volume 3, Issues 3-4, July-December, 2015
4 ISAC et al. with both ASD and ADHD have specific pharmacological treatment. The most prescribed drugs for the ADHD treatment by psychiatrists are stimulants and non-stimulants. In our sample this classes of ADHD drugs are prescribed equally (7 patients received metilphenidate and 8 patients received atomoxetine). DISCUSSIONS Our data offers an image of the usual prescribing pharmacological drugs practices for children with autism. We found that in our sample all the patients had at least one comorbidity recorded in their medical file following ASD diagnosis, the most common being ADHD and mental disabilities. Simonoff et al. [1] found in their SNAP cohort that 28.2% were comorbid with ADHD, 30.0% had oppositional or conduct disorder and 41.9 % had anxiety or phobias; our sample had much higher proportions of ADHD and much lower proportions of others comorbidities. These differences may appear due to communication impairment or cognitive problems in individuals [6] and diagnose difficulties. Pharmacological interventions may increase the ability of persons with ASD to benefit from education and other interventions, and to remain in less restrictive environments through the management of severe and challenging behaviors % of our sample received psychotropic drug prescriptions in clinical care. In contrast, Mandell et al. [7] found that 56% of Medicaid-enrolled youths with ASDs aged 0 21 years received at least one psychotropic drug. There was no more conservative use of psychotropic drugs in our ASD sample compared with the practices described in others studies. In the past two decades, advances in the pharmacological treatment of children and adolescents in psychiatry have resulted in the use of typical and atypical antipsychotics to target specific symptoms for a variety of disorders, including bipolar disorder, schizophrenia, obsessive compulsive disorders or ASD. Poor frustration tolerance, impulsivity, aggression, mood instability are among the various symptoms treated with antipsychotics. Since the late 1990s, there has been a transition from the use of typical antipsychotics such as haloperidol, chlorpromazine, and fluphenazine to atypical antipsychotics such as risperidone, olanzapine, quetiapine, and aripiprazole in the treatment of these symptoms. Recently, in children and adolescents with autism, antipsychotic medications have been used more frequently to treat symptoms of irritability, aggression, and selfinjury. In our sample almost half of the patients received atypical antipsychotics. A recent survey looking specifically at psychotropic drug use in children with pervasive developmental disorders revealed that half of the patients were currently being prescribed a psychotropic drug, and approximately 16.5% were taking an antipsychotic drug in conjunction with behavioral interventions, such as applied behavioral analysis [8]. Others studies have shown that 24 31% of individuals with ASD have taken an atypical antipsychotic. This has led to this class of medications accounting for the majority of prescriptions in the ASD population [7]. We found in our study a large proportion of specific ADHD treatment (stimulant and nonstimulant) prescriptions. The increase in the prescription of these drugs over time may reflect the increasing recognition of comorbid ADHD (and its persistence) in young people with ASDs. Our results are similar with those found by Simonoff et al. [1] or Frazier et al. [2]. More recently, optimal dosing of methylphenidate was shown to be effective in reducing ADHD symptoms in about 40 % of children with intellectual disability. Romanian Journal of Child and Adolescent Psychiatry
5 Pharmacological therapy of Autism Spectrum Disorders in the clinical practice Two thirds of the autistic population is reported as having moderate sleep disturbances [9]; however, no patient in our sample received sleep medication or benzodiazepines; it is likely that physicians only consider prescribing pharmacological treatments to patients with severe sleeping disorders or they avoid prescribing these classes of drugs all together. CONCLUSIONS Treatment of core and associated symptoms of autism spectrum disorder should be multimodal. Use of medication should be directed toward specific, clearly identified target symptoms or comorbid condition. The only US FDA-approved medications in individuals with ASD are risperidone and aripiprazole. They are both approved for the treatment of irritability in youths with autism. In our sample, 79.41% of children receive at least one psychotropic drug prescription, mostly for atypical antipsychotics and specific ADHD treatment (stimulant and non-stimulant). Hence, further research into the appropriate use, efficacy and longterm safety of any drugs in autistic population is warranted to support clinical practice for optimal and safe treatment of ASDs and their comorbidities. pharmacological treatments for adolescents and adults with autism spectrum disorder. Autism 11(4): Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F (2004). Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics. Nov;114(5):e Marcus RN, Owen R, Kamen L, Manos G, McQuade RD, Carson WH, Aman MG (2009), A placebocontrolled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry. Nov;48(11): Leyfer OT, Folstein SE, Bacalman S, Davis NO, Dinh E, Morgan J, Tager-Flusberg H, Lainhart JE (2006), Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. JAutismDev Disord. 7. Mandell DS, Morales KH, Marcus SC, Stahmer AC, Doshi J, Polsky DE (2008) Psychotropic medication use among Medicaid enrolled children with autism spectrum disorders. Pediatrics 121(3):e441 e Aman M.G., Lam K., Van Bourgondien M.E. (2005). Medication patterns in patients with autism: Temporal, regional and demographic influences. Journal of Child and Adolescent Psychopharmacology, Vol. 15, No 1 9. Souders MC, Mason TB, Valladares O, Bucan M, Levy SE, Mandell DS, Weaver TE, Pinto-Martin J. (2009), Sleep behaviors and sleep quality in children with autism spectrum disorders. Sleep.;32(12): REFERENCES 1. Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G (2008) Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a populationderived sample. J Am Acad Child Adolesc Psychiatry 47(8): Frazier TW, Shattuck PT, Narendorf SC, Cooper BP, Wagner M, Spitznagel EL. Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiverreported attention-deficit/ hyperactivity disorder. J Child AdolescPsychopharmacol Dec;21(6): Broadstock M, Doughty C, Eggleston M (2007) Systematic review of the effectiveness of Volume 3, Issues 3-4, July-December, 2015
6 ISAC et al. Romanian Journal of Child and Adolescent Psychiatry
COMORBIDITIES ASSOCIATED WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER IN PRESCHOOLERS
ANTON et al. ORIGINAL PAPERS COMORBIDITIES ASSOCIATED WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER IN PRESCHOOLERS Teodora PANAITESCU 2, Andra ISAC 2, Ruqiya NOOR 1, Elena PREDESCU 1, Viorel LUPU 1, Ioana
More informationCHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX
A Adderall Counterfeit, 31 addiction, internet CBT, 55 ADHD Adjunctive Guanfacine, 11 Counterfeit Adderall, 31 Developmental Trajectory and Risk Factors, 5 Dopamine Transporter Alterations, 14 Extended-Release
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice 1 Guideline title SCOPE Autism: the management and support of children and young people on the autism spectrum 1.1 Short
More informationKelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009
Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009 List the antipsychotics most often prescribed Compare and contrast the use and adverse effects experienced in the pediatric
More informationTable 1 Results of the 12-item General Health Questionnaire among caregivers who were or were not evacuated Not evacuated (N=46)
Table 1 Results of the 12-item General Health Questionnaire among caregivers who were or were not evacuated Not evacuated (N=46) Evacuated (N=46) Item N % N % 2a p Unable to concentrate 4 4 20 22 14.4
More informationPediatric Psychopharmacology
Pediatric Psychopharmacology General issues to consider. Pharmacokinetic differences Availability of Clinical Data Psychiatric Disorders can be common in childhood. Early intervention may prevent disorders
More informationPiecing the Puzzle Together: Pharmacologic Approaches to Behavioral Management in Autism Spectrum Disorder
Piecing the Puzzle Together: Pharmacologic Approaches to Behavioral Management in Autism Spectrum Disorder Hannah Sauer, PharmD PGY1 Pediatric Pharmacy Resident Mayo Clinic 2015 MFMER slide-1 Objectives
More informationAggression (Severe) in Children under Age 6
Aggression (Severe) in Children under Age 6 Level 0 Comprehensive diagnostic assessments. Refer to Principles of Practice on page 6. Evaluate and treat comorbid conditions (i.e. medical, other psychiatric
More information6/22/2012. Co-morbidity - when two or more conditions occur together. The two conditions may or may not be causally related.
Autism Spectrum Disorders and Co-existing Mental Health Issues By Dr. Karen Berkman Objective To present an overview of common psychiatric conditions that occur in persons with autism spectrum disorders
More informationDisclosures. Autism Society of Wisconsin. Case 2. Case 1. Case 3. Case 4 3/29/2018. Medication treatment for people with Autism Spectrum Disorder
Medication treatment for people with Autism Spectrum Disorder Autism Society of Wisconsin April 20, 2018 Richard P. Barthel, M.D. Disclosures In accordance with the ACCME policy on relevant financial disclosure,
More informationPharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care
Psychopharmacology (2014) 231:1011 1021 DOI 10.1007/s00213-013-3140-7 ORIGINAL INVESTIGATION Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care Macey
More informationBrief Notes on the Mental Health of Children and Adolescents
Brief Notes on the Mental Health of Children and Adolescents The future of our country depends on the mental health and strength of our young people. However, many children have mental health problems
More informationPediatric Primary Care Mental Health Specialist Certification Exam. Detailed Content Outline
Pediatric Primary Care Mental Health Specialist Certification Exam Detailed Content Outline Description of the Specialty The Pediatric Primary Care Mental Health Specialist (PMHS) builds upon the Advanced
More informationPrevalence of Comorbidity and Pattern Drug Use among Children with Attention-deficit hyperactivity disorder: A Single Center in Thailand
The 25th Federation Of Asian Pharmaceutical Association (FAPA) Congress 2014 Kota Kinabalu, Sabah, Malaysia 9th - 12th October, 2014 Prevalence of Comorbidity and Pattern Drug Use among Children with Attention-deficit
More informationAutism Spectrum Disorder What is it? Robin K. Blitz, MD Resident Autism Diagnostic Clinic Lecture Series #1
Autism Spectrum Disorder What is it? Robin K. Blitz, MD Resident Autism Diagnostic Clinic Lecture Series #1 Learning Objectives What can we talk about in 20 minutes? What is Autism? What are the Autism
More informationDr Keith Ganasen Department of Psychiatry UCT
Dr Keith Ganasen Department of Psychiatry UCT A. Significantly subaverage intellectual functioning: an IQ of approximately 70 or below on an individually administered IQ test B. Concurrent deficits or
More informationAutism Spectrum Disorder What is it?
Autism Spectrum Disorder What is it? Robin K. Blitz, MD Resident Autism Diagnostic Clinic Lecture Series #1 Learning Objectives What can we talk about in 20 minutes? What is Autism? What are the Autism
More informationCHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX
A acceptance and commitment therapy Posttraumatic Stress, 69 ADHD Adjunctive Fatty Acids, 5 Adjunctive Guanfacine Pharmacokinetics, 27 Amantadine, 21 Atomoxetine, 23 Cancer Risk, 31 CBT for Comorbid Anxiety,
More informationMedications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation
Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral
More information3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder
Cynthia King, MD Associate Professor of Psychiatry UNMSOM Autism Spectrum Disorder 1 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive
More information3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM
Cynthia King, MD Associate Professor of Psychiatry UNMSOM 1 2 Autism Spectrum Disorder 3 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive
More informationFL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality
FL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality April 23, 2014 Pensacola, FL Presentation Objectives To briefly describe the program and how its components
More informationUnderstanding the Use of Psychotherapy and Psychotropic Medications for Oppositional Defiance and Conduct Disorders. Prof.
Understanding the Use of Psychotherapy and Psychotropic Medications for Oppositional Defiance and Conduct s Prof. Daniel Kaplin College of Staten Island One of the new chapters in the Diagnostic and Statistical
More informationQ&A Summary: Autism Spectrum Disorder (ASD) Part II: Medical Home Care for Children With ASD and Other Developmental Disabilities
Q&A Summary: Autism Spectrum Disorder (ASD) Part II: Medical Home Care for Children With ASD and Other Developmental Disabilities Available On-Demand: optumhealtheducation.com/autism-part-ii-2018 Presenter:
More informationTools that make a difference in mental health symptoms of autistic spectrum children Sumru Bilge-Johnson M.D. Program Director of Child Psychiatry
Tools that make a difference in mental health symptoms of autistic spectrum children Sumru Bilge-Johnson M.D. Program Director of Child Psychiatry Fellowship Associate Professor, Child Psychiatry NEOMED
More informationCERTIFICATION EXAMINATION IN CHILD AND ADOLESCENT PSYCHIATRY Content Blueprint (October 26, 2015)
CERTIFICATION EXAMINATION IN CHILD AND ADOLESCENT PSYCHIATRY 2016 Content Blueprint (October 26, 2015) Number of questions: 280 1. Development 13 17% 2. Biological and clinical science 13 17% 3. Psychopathology/Classification
More informationObsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care
Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care CLINICAL ASSESSMENT AND DIAGNOSIS (ADULTS) Obsessive-Compulsive Disorder (OCD) is categorized by recurrent obsessions,
More informationUse of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia
Use of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia Aine Leen, Kieran Walsh, David O Sullivan, Denis O Mahony, Stephen Byrne, Margaret Bermingham Pharmaceutical Care Research Group,
More informationMedications in Autism: What We Know and Don't Know
Medications in Autism: What We Know and Don't Know Jeremy Veenstra-VanderWeele, M.D. Mortimer D. Sackler, M.D., Associate Professor Center for Autism and the Developing Brain Sackler Institute for Developmental
More informationD I A G N O S I S ADD/ADHD. Conduct Disorder. Oppositional. Oppositional Defiant Disorder. Defiant. Anxiety Disorder. Adjustment.
Dr. Crismon has no potential conflicts of interest to disclose with regard to this presentation. M. Lynn Crismon, Pharm.D., FCCP, BCPP Dean James T. Doluisio Regents Chair & Behrens Centennial Professor
More informationAutism/Pervasive Developmental Disorders Update. Kimberly Macferran, MD Pediatric Subspecialty for the Primary Care Provider December 2, 2011
Autism/Pervasive Developmental Disorders Update Kimberly Macferran, MD Pediatric Subspecialty for the Primary Care Provider December 2, 2011 Overview Diagnostic criteria for autism spectrum disorders Screening/referral
More informationCERTIFICATION EXAMINATION IN CHILD AND ADOLESCENT PSYCHIATRY Content Blueprint (October 17, 2018)
CERTIFICATION EXAMINATION IN CHILD AND ADOLESCENT PSYCHIATRY 2019 Content Blueprint (October 17, 2018) Number of questions: 280 1. Development 13 17% 2. Biological and clinical science 13 17% 3. Psychopathology/Classification
More informationPromoting and Monitoring Evidenced-Based Antipsychotic Prescribing Practices in Children and Adolescents: Florida Medicaid Initiatives
Promoting and Monitoring Evidenced-Based Antipsychotic Prescribing Practices in Children and Adolescents: Florida Medicaid Initiatives Mary Elizabeth Jones, Pharm BSc, RPh Senior Pharmacist AHCA Pharmacy
More informationStrathprints Institutional Repository
Strathprints Institutional Repository Akram, Gazala (2015) Profiling psychotropic discharge medication from a children s psychiatric ward. International Journal of Clinical Pharmacy, 37 (5). pp. 753-757.
More informationComorbidities in Teenagers Pathological and Problem Gambling in Romania National Study Viorel Lupu*, Izabela Ramona Lupu**
Comorbidities in Teenagers Pathological and Problem Gambling in Romania National Study Viorel Lupu*, Izabela Ramona Lupu** *Assoc.Prof.MD.,Ph.D. Iuliu Hatieganu University of Medicine and Pharmacy Cluj-
More informationRole of ADHD medication in children with autism spectrum disorder. Pieter Hoekstra University of Groningen, Netherlands
Role of ADHD medication in children with autism spectrum disorder Pieter Hoekstra University of Groningen, Netherlands Symptoms of ADHD are highly prevalent in children with ASD Two independent chart reviews
More informationGOALS FOR THE PSCYHIATRY CLERKSHIP
GOALS FOR THE PSCYHIATRY CLERKSHIP GOALS - The aim of the core psychiatry clerkship is to expose students to patients with mental illness and to prepare them to provide psychiatric care at a basic level.
More informationOutpatient use of Atypical Antipsychotic Agents in the Pediatric Population Years
Outpatient use of Atypical Antipsychotic Agents in the Pediatric Population Years 2004-2008 Laura Governale, Pharm.D., MBA Team Leader, Drug Utilization Data Analyst Hina Mehta, Pharm.D. Drug Utilization
More informationAutism Spectrum Disorder and Mental Health Challenges in Youth
Autism Spectrum Disorder and Mental Health Challenges in Youth Management in the Primary Care Setting February 13, 2016 Rebecca Marshall, MD, MPH Outline DSM V Criteria Comorbidities Behavioral treatments
More information2. Did the member receive this medication during a recent hospitalization? Y N
Pharmacy Prior Authorization AETA BETTER HEALTH PESLVAIA & AETA BETTER HEALTH KIDS Antipsychotics (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review
More informationAutism Spectrum Disorder What is it?
Autism Spectrum Disorder What is it? Robin K. Blitz, MD Director, Developmental Pediatrics Resident Autism Diagnostic Clinic Lecture Series #1 Learning Objectives What can we talk about in 20 minutes?
More information2. Did the patient receive this medication during a recent hospitalization? Y N
Pharmacy Prior Authorization AETA BETTER HEALTH PESLVAIA & AETA BETTER HEALTH KIDS Antipsychotics (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review
More informationIndex. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers
Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic
More informationRESEARCH. What is already known about this subject
RESEARCH Comparative Treatment Patterns, Resource Utilization, and Costs in Stimulant-Treated Children with ADHD Who Require Subsequent Pharmacotherapy with Atypical Antipsychotics Versus Non-Antipsychotics
More informationPaediatric Psychopharmacology. Dr Jalpa Bhuta. MD, DNB, MRCPsych (UK).
Paediatric Psychopharmacology. Dr Jalpa Bhuta. MD, DNB, MRCPsych (UK). Childhood pharmacokinetics Children have greater hepatic capacity More glomerular filtration Less fatty tissue Less ability to store
More informationPSYCHOTROPIC MEDICATION UTILIZATION PARAMETERS FOR CHILDREN AND YOUTH IN FOSTER CARE
PSYCHOTROPIC MEDICATION UTILIZATION PARAMETERS FOR CHILDREN AND YOUTH IN FOSTER CARE Introduction and General Principles April 2017 Adapted for New Mexico from with permission from the Texas Department
More informationAutism and Other Autism Spectrum Disorders (ASDs) or Pervasive Developmental Disorders (PDDs)
June 11, 2008 Autism and Other Autism Spectrum Disorders (ASDs) or Pervasive Developmental Disorders (PDDs) Institute for Development of Mind and Behavior Masataka Ohta MD (Email: mohta-dmb@nifty.com)
More informationIntroduction to Abnormal Psychology
Introduction to Abnormal Psychology Truth or Fiction? In the Middle Ages, innocent people were drowned as a way of proving that they were not possessed by the Devil. People with schizophrenia may see and
More informationHow does risperdal work for autism
How does risperdal work for autism The FDA approved the use of risperidone or Risperdal orally disintegrating tablets for the treatment of. Risperdal as a Treatment for Autism By Vincent. Schizophrenia
More informationWORKBOOK ANSWERS CHAPTER 14 MENTAL DISORDERS
WORKBOOK ANSWERS CHAPTER 14 MENTAL DISORDERS 1. POSTTRAUMATIC STRESS DISORDER SHORT ANSWERS 2. ALZHEIMER DISEASE 3. STRESS IS CONSIDERED A CONTRIBUTING FACTOR CAUSING EXACERBATION OF MENTAL DISORDERS.
More informationAutism and Other Autism Spectrum Disorders (ASD) or Pervasive Developmental Disorders (PDD)
June 22, 2011 Autism and Other Autism Spectrum Disorders (ASD) or Pervasive Developmental Disorders (PDD) Institute for Development of Mind and Behavior Masataka Ohta MD (Email: mohta-dmb@nifty.com) OUTLINE
More informationUnit 1. Behavioral Health Course. ICD-10-CM Specialized Coding Training. For Local Health Departments and Rural Health
ICD-10-CM Specialized Coding Training http://publichealth.nc.gov/lhd/icd10/training.htm Behavioral Health Course For Local Health Departments and Rural Health Unit 1 1 Behavioral Health Training Objectives
More informationtopic : Co-Morbid Conditions by Cindy Ring, MSW, LSW and Michele LaMarche, BCBA
ABA Literature Summary e-newsletter OCTOBER 2011 ISSUE 5 topic : Co-Morbid Conditions by Cindy Ring, MSW, LSW and Michele LaMarche, BCBA 1. Co-Morbidity Rates and Types in Individuals with Autism............
More informationAttention-Deficit/Hyperactivity Disorder Nathan J. Blum, M.D.
ADHD in Preschool Children Preschool ADHD: When Should We Diagnose it & How Should We Treat it? Professor of Pediatrics Diagnosis of ADHD in Preschool Children: Impact of DSM-IV Is Preschool ADHD Associated
More informationAutism Spectrum Disorder
Autism Spectrum Disorder 1) Approximately 1 out of every children in the United States will have an ASD. a) 44 b) 88 c) 122 d) 244 2) Asperger s syndrome presents more frequently in boys than it does in
More informationTreatment for Co-Occurring Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder
Neurotherapeutics DOI 10.1007/s13311-012-0126-9 REVIEW Treatment for Co-Occurring Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder Naomi Ornstein Davis Scott H. Kollins # The American
More informationUse of antipsychotic medications
Evidence-Based Use of Second-Generation Antipsychotics in a State Medicaid Pediatric Population, 2001 2005 Prathamesh Pathak, M.S., B.Pharm. Donna West, Ph.D. Bradley C. Martin, Pharm.D., Ph.D. Mark E.
More informationChallenging ASD Cases November 11, Melanie Penner, MD, MSc, Mohammad Zubairi, MD, MEd,
Challenging ASD Cases November 11, 2017 Melanie Penner, MD, MSc, FRCPC @drmelpenner Mohammad Zubairi, MD, MEd, FRCPC @md_mszubairi Learning Objectives By the end of this workshop, participants will: 1)
More informationDr Jane McCarthy Consultant Psychiatrist, East London NHS Foundation Trust & Visiting Senior Lecturer, Department of Forensic & Neurodevelopmental
Dr Jane McCarthy Consultant Psychiatrist, East London NHS Foundation Trust & Visiting Senior Lecturer, Department of Forensic & Neurodevelopmental Sciences Department, King s College London Prevalence
More informationMODEL PSYCHOPHARMACOLOGY CURRICULUM
Third Edition MODEL PSYCHOPHARMACOLOGY CURRICULUM For Psychiatric Residency Programs, Training Directors and Teachers of Psychopharmacology VOLUME I By A Committee of the American Society of Clinical Psychopharmacology
More informationPrescribing for people with a personality disorder. POMH-UK QIP 12b
Prescribing for people with a personality disorder POMH-UK QIP 12b Personality disorder Personality disorders are a heterogeneous group of conditions which vary greatly in their severity Characterised
More informationDifferential Diagnosis. Not a Cookbook. Diagnostic Myths. Starting Points. Starting Points
Educational Identification of Individuals with Autism Spectrum Disorders Ohio Center for Autism and Low Incidence (OCALI) 5220 N. High Street Columbus, OH 43214 Main Line: 866-886-2254 Fax: 614-410-1090
More informationCorrespondence should be addressed to Vitharon Boon-yasidhi;
Psychiatry Journal, Article ID 136158, 4 pages http://dx.doi.org/10.1155/2014/136158 Research Article Adverse Effects of Risperidone in Children with Autism Spectrum Disorders in a Naturalistic Clinical
More informationATTENTION DEFICIT HYPERACTIVITY DISORDER COMORBIDITIES 23/02/2011. Oppositional Defiant Disorder
ATTENTION DEFICIT HYPERACTIVITY DISORDER COMORBIDITIES The comorbidity of ADHD with other disorders is between 60% and 80% The most commonly comorbid disorder that occur alongside ADHD are: Oppositional
More informationOklahoma Psychological Association DSM-5 Panel November 8-9, 2013 Jennifer L. Morris, Ph.D.
Oklahoma Psychological Association DSM-5 Panel November 8-9, 2013 Jennifer L. Morris, Ph.D. DSM-5 continues developmental progression, starting with disorders that are observed in early life. Disorders
More informationAUTISM SPECTRUM DISORDER: DSM-5 DIAGNOSTIC CRITERIA. Lisa Joseph, Ph.D.
AUTISM SPECTRUM DISORDER: DSM-5 DIAGNOSTIC CRITERIA Lisa Joseph, Ph.D. Autism Spectrum Disorder Neurodevelopmental disorder Reflects understanding of the etiology of disorder as related to alterations
More informationMental Health & Your Teen Tools, Strategies & Resources
3 rd Annual 22q11DS Family Conference Mental Health & Your Teen Tools, Strategies & Resources Dr. Claire De Souza Child & Adolescent Psychiatrist Medical Director, Consultation-Liaison Psychiatry Program
More informationDSM Comparison Chart DSM-5 (Revisions in bold)
317.0-318.2 DSM Comparison Chart DSM-IV-TR DSM-5 (Revisions in bold) Multi-axial system s Usually First Diagnosed in Infancy, Childhood and Adolescence Single line diagnosis with specifiers Neurodevelopmental
More informationDisclosure Statement. A Rational Approach to Psychopharmacology. Goals 10/28/2013
A Rational Approach to Psychopharmacology Disclosure Statement Full time employed physician with MaineGeneral Medical Center in Waterville and Augusta No conflicts of interest to disclose Goals Promote
More informationJessica A. Hellings, MD, MB.BCh., M.Med Psych.
Autism Spectrum Disorders Jessica A. Hellings, MD, MB.BCh., M.Med Psych. Director Neurodevelopmental Psychiatry Study Program The Ohio State University Nisonger Center The Ohio State University Wexner
More informationIV. Additional information regarding diffusion imaging acquisition procedure
Data Supplement for Ameis et al., A Diffusion Tensor Imaging Study in Children with ADHD, ASD, OCD and Matched Controls: Distinct and Non-distinct White Matter Disruption and Dimensional Brain-Behavior
More informationPharmacy Prior Authorization GMH/SA and Non-Title 19/21 SMI Non-Formulary and Prior Authorization Guidelines
Non-Formulary Behavioral Health Medications ADHD medications for children under The patient must have a diagnosis for which the requested medication is: o Approved based on FDA indication and limits; OR
More informationDifferential Diagnosis. Differential Diagnosis 10/29/14. ASDs. Mental Health Disorders. What Else Could it Be? and
Differential Diagnosis ASDs and Mental Health Disorders - Matt Reese, PhD Differential Diagnosis What Else Could it Be? Differential Diagnosis: The process of distinguishing one disorder from others which
More informationAutism and Other Autism Spectrum Disorders (ASD) or Pervasive Developmental Disorders (PDD)
June 22, 2011 Autism and Other Autism Spectrum Disorders (ASD) or Pervasive Developmental Disorders (PDD) Institute for Development of Mind and Behavior Masataka Ohta MD (Email: mohta-dmb@nifty.com) OUTLINE
More informationSECTION 1. Children and Adolescents with Depressive Disorder: Summary of Findings. from the Literature and Clinical Consultation in Ontario
SECTION 1 Children and Adolescents with Depressive Disorder: Summary of Findings from the Literature and Clinical Consultation in Ontario Children's Mental Health Ontario Children and Adolescents with
More informationWeek 2: Disorders of Childhood
Week 2: Disorders of Childhood What are neurodevelopmental disorders? A group of conditions with onset in the developmental period Disorders of the brain The disorders manifest early in development, often
More informationPrescribing antipsychotics for children and adolescents
POMH-UK Topic 10a baseline report Prescribing antipsychotics for children and adolescents September 2010 Prepared by the Prescribing Observatory for Mental Health-UK for Coventry and Warwickshire Partnership
More informationPersonnel blinding. Assessor blinding
Table S1: Cochrane Risk of bias within studies Study Sequence generation Allocation concealment Participant blinding Personnel blinding Assessor blinding Incomplete outcome data Selective outcome reporting
More information5/2/2017. By Pamela Pepper PMH, CNS, BC. DSM-5 Growth and Development
By Pamela Pepper PMH, CNS, BC DSM-5 Growth and Development The idea that diagnosis is based on subjective criteria and that those criteria should fall neatly into a set of categories is not sustainable,
More informationThe Mental Health and Wellbeing of Children and Adolescents who are affected by Autism and Related Disorders
The Mental Health and Wellbeing of Children and Adolescents who are affected by Autism and Related Disorders Charles Cartwright, M.D Director: YAI Autism Center March 2013 Autism Spectrum Defined by the
More informationAn Autism Primer for the PCP: What to Expect, When to Refer
An Autism Primer for the PCP: What to Expect, When to Refer Webinar November 9, 2016 John P. Pelegano MD Chief of Pediatrics Hospital for Special Care Disclosures None I will not be discussing any treatments,
More informationU.S. 1 February 22, 2013
U.S. 1 February 22, 2013 A Placebo-controlled, Randomized, Blinded, Dose Finding Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults Study Code: MAA-1 Sponsor: Multidisciplinary
More informationRutgers University Course Syllabus Atypical Child and Adolescent Development Fall 2016
Rutgers University Course Syllabus Atypical Child and Adolescent Development Fall 2016 Date & Time: Mon and Wedn. 1:40 3:00 pm Location: Pharm. Rm 111 Busch Campus Instructor: Stevie M. McKenna MA E-Mail:
More informationPsychopharmacology of Autism Spectrum Disorder
Psychopharmacology of Autism Spectrum Disorder Christopher J. McDougle, MD Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral Hospital
More informationTreatment of Autism Spectrum Disorder in Children and Adolescents
Evidence-Based Medicine Key Words: autism spectrum disorder, treatment, psychotherapy, psychopharmacology Treatment of Autism Spectrum Disorder in Children and Adolescents By Melissa DeFilippis, Karen
More informationComorbidity. Psychiatric Comorbidity
Rachel Loftin, Ph.D. Autism Assessment, Research & Treatment Services (AARTS) Rush University Medical Center Comorbidity Medical comorbidity Seizures GI (24% in one study) Infections Feeding Issues Etc.
More informationA Longitudinal Pilot Study of Behavioral Abnormalities in Children with Autism
Volume 1, Issue 4 Research Article A Longitudinal Pilot Study of Behavioral Abnormalities in Children with Autism Robin A. Libove 1, Thomas W. Frazier 2, Ruth O Hara 1, Jennifer M. Phillips 1, Booil Jo
More informationAggression (Severe) in Children under Age 6
ggression (Severe) in Children under ge 6 Level 0 Comprehensive diagnostic assessment (see Principles of Practice). Level 1 Psychosocial intervention. Evidence-based psychotherapeutic interventions such
More information156 Index. treatment, 31 Externalizing behavior adaptive functioning, 23, 25, 26 aggressive behavior, 26 behavioral issues, role in, 26 PWS, 35
Index A Adaptive functioning, 23, 25 26, 28 Adolescents, 7. See also Youth ASD (see also Autism spectrum disorder (ASD)), 15 Angelman syndrome, 28 Aripiprazole, 93 94 Antihistamines, 92 Anxiety, 89, 92,
More informationChildhood ADHD is a risk factor for some Psychiatric Disorders and co-morbidities
Childhood ADHD is a risk factor for some Psychiatric Disorders and co-morbidities By: Dr. Ehsane M. Gad M.B.B.Ch CABMSPsych. D.P.P Post-Fellow Aus. Consultant Child Psychiatry Childhood ADHD and emergence
More information8/23/2017. Chapter 21 Autism Spectrum Disorders. Introduction. Diagnostic Categories within the Autism Spectrum
Chapter 21 Overview Core features of autism spectrum disorders (ASDs) Studies seeking an etiology for ASDs Conditions associated with ASDs Interventions and outcomes Introduction ASDs Class of neurodevelopmental
More informationMental Health Services Act. Transforming the Santa Barbara County System of Care. Data Report: Santa Barbara County and System of Care
1 Mental Health Services Act Transforming the Santa Barbara County System of Care Data Report: Santa Barbara County and System of Care Prepared by: April Howard, M.A. Departmental Analyst Santa Barbara
More informationDr Jane McCarthy MB ChB MD MRCGP FRCPsych
Dr Jane McCarthy MB ChB MD MRCGP FRCPsych Consultant Psychiatrist in Intellectual Disability, East London NHS Foundation Trust and Visiting Senior Lecturer, Institute of Psychiatry, Psychology & Neuroscience,
More informationAn Overview of the ADHD Pathway for Adults in Devon/Torbay
An Overview of the ADHD Pathway for Adults in Devon/Torbay Andrew Blewett, also Charles Antwi, Mark Jay, Ruth Marlow, Rachel Pebworth, Abbie Turner, Rachel Webb January 2016 Resource/capacity 0.8 clinical
More informationM Saccani 1*, E Buzzi 2, F Paccione 2. Licensee OAPL (UK) Creative Commons Attribution License (CC-BY) Effective Clinical Care.
Page 1 of 5 Effective Clinical Care The relationship between autism spectrum disorder and attentiondeficit hyperactivity disorder: A critical review of the effects of DSM 5 criteria and the implications
More informationBipolar Disorder in Youth
Bipolar Disorder in Youth Janet Wozniak, M.D. Associate Professor of Psychiatry Director, Pediatric Bipolar Disorder Research Program Harvard Medical School Massachusetts General Hospital Pediatric-Onset
More informationReferral trends in mental health services for adults with intellectual disability and autism spectrum disorders
Referral trends in mental health services for adults with intellectual disability and autism spectrum disorders autism 2007 SAGE Publications and The National Autistic Society Vol 11(1) 9 17; 070987 1362-3613(200701)11:1
More informationIntroduction to Magellan s Adopted Clinical Practice Guidelines for the Treatment of Children with Autism Spectrum Disorders
Introduction to Magellan s Adopted Clinical Practice Guidelines for the Treatment of Children with Autism Spectrum Disorders 1 Task Force Membership J. Andrew Burkins, M.D. Robert Ciaverelli, M.D. Kathleen
More informationUpdate on First Psychotic Episodes in Childhood and Adolescence. Cheryl Corcoran, MD Assistant Professor of Psychiatry Columbia University
Update on First Psychotic Episodes in Childhood and Adolescence Cheryl Corcoran, MD Assistant Professor of Psychiatry Columbia University Childhood-Onset Psychosis 8% of psychiatrically referred youth
More information